Dedicated to Creating a “Hundred Questions Encyclopedia” for Atrial Fibrillation, Supporting Standardized Diagnosis, Treatment, and Scientific Management
ShanghaiJune 5, 2026 /PRNewswire/ — On the occasion of the upcoming 14th China Atrial Fibrillation Day, the “Atrial Fibrillation: 100 Questions & Answers Book,” co-created by Johnson & Johnson MedTech and DXY, was officially released. This communication tool is based on authoritative consensus and evidence-based evidence related to atrial fibrillation diagnosis and treatment, integrating the clinical experience of experts in the field of cardiac electrophysiology. It systematically distills one hundred Q&A entries addressing common patient issues encountered in clinical practice, aiming to support doctors in conducting disease explanations and communication more efficiently and standardly, thereby providing patients with clear, understandable, and actionable management recommendations for atrial fibrillation.
Li Miao, Vice President of the Cardiac Electrophysiology Business Unit at Johnson & Johnson MedTech China, stated: “Atrial fibrillation is an arrhythmia disease that requires long-term standardized management. Clinically, we often see that patients’ insufficient understanding of the risks and treatment benefits of atrial fibrillation can lead to delayed evaluation, poor compliance, or interrupted follow-up. The release of this ‘Atrial Fibrillation: 100 Questions & Answers Book’ aims to transform complex medical information into easily understandable common knowledge, providing doctors across different regions and healthcare levels with a standardized and systematic tool for doctor-patient communication. In the future, we will continue to collaborate with experts and industry partners to promote standardized diagnosis, treatment, and comprehensive management of atrial fibrillation, benefiting more patients.”
Li Tian, Founder and Chairman of DXY, stated: “The difficulty in doctor-patient communication during atrial fibrillation management often lies in whether professional knowledge can be correctly understood, effectively accepted, and acted upon by patients. The ‘Atrial Fibrillation: 100 Questions & Answers Book’ focuses on high-frequency clinical issues, providing answers in language close to everyday life. It aims to help doctors convey diagnosis and treatment information more time-efficiently and effectively, while also allowing patients to understand and accept it easily during consultations. We also hope to collaborate with excellent partners like Johnson & Johnson MedTech to create more ready-to-use tools, contributing further to the standardized management of atrial fibrillation.”
Atrial fibrillation is a common arrhythmia disease that not only affects quality of life but is also closely linked to serious events such as ischemic stroke and heart failure. According to statistics, China currently has over 20 million patients with atrial fibrillation[1], and the incidence rate increases significantly with age, with the prevalence rate even reaching 12% in the 75-84 age group[2]. Facing a large patient population and regional differences in diagnosis and treatment, promoting a more standardized and unified model for atrial fibrillation diagnosis, treatment, and management is key to improving overall treatment quality and truly helping patients achieve long-term benefits.
The “Atrial Fibrillation: 100 Questions & Answers Book” project was officially launched at the 36th Great Wall International Congress of Cardiology and the Asian Heart Congress in October 2025. Since its launch, the project has collaborated with multiple experts in the field of cardiac electrophysiology in China, continuously refining content around high-frequency communication scenarios in clinical diagnosis and treatment. Through the aggregation of expert experience and multiple iterations, scattered clinical experience and authoritative consensus have been systematically integrated into structured Q&A, ultimately forming a communication tool that combines professional depth with practical value.
The content of this communication tool covers fundamental knowledge of atrial fibrillation, diagnostic evaluation, treatment options, and daily lifestyle management, focusing on addressing “questions patients want to ask and common issues in outpatient settings.” Through standardized communication prompts and easy-to-understand expressions, this content can serve as a practical tool for doctors in daily outpatient visits and follow-ups, helping them clearly and effectively convey key treatment benefits and important precautions within limited communication time, thereby enhancing the efficiency of doctor-patient communication and patient understanding.
For many years, Johnson & Johnson MedTech has been deeply involved in the field of cardiac electrophysiology, continuously promoting the application of standardized diagnosis, treatment, and innovative technologies in clinical practice. Taking the opportunity of China Atrial Fibrillation Day, the company hopes that through the “Atrial Fibrillation: 100 Questions & Answers Book,” it can help doctors more effectively convey disease awareness and management goals during patient communication, integrate scientific and standardized atrial fibrillation management concepts into daily clinical scenarios, and assist atrial fibrillation patients in better returning to a full “heart” life.